This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Cha Biolab Co., Ltd., Cha Biotech Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 8 Years Active: 2025
Title: In Jee Lee: Advancing Natural Killer Cell Immunotherapy
Introduction
In Jee Lee is an inventor based in Seongnam, South Korea. His work includes research into natural killer cells and their potential to support cancer immunotherapy.
Latest Patents
Lee is associated with 1 patent, titled “Natural Killer Cells Exhibiting Increased Anticancer Activity and Immunotherapeutic Use Thereof.” The invention describes natural killer cells with increased anticancer activity. It reports an increase in the relative mean fluorescence intensity of a specific receptor relevant to cancers, including glioblastoma, with the aim of enabling effective anticancer immunotherapy.
Career Highlights
Lee has been associated with Cha Biolab Co., Ltd. and CHA Biotech Co., Ltd. His patent reflects work focused on the therapeutic potential of natural killer cells.
Collaborations
Lee’s listed coworker is Young Seok Baek. Their shared research context includes the development of natural killer cell-based approaches to cancer treatment.
Conclusion
In Jee Lee’s patent work highlights an effort to strengthen cancer immunotherapy by enhancing the anticancer activity of natural killer cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile